Key result
Drug-eluting stents have an uncertain long-term safety profile regarding the risk of late thrombosis despite their widespread adoption in percutaneous coronary interventions.
Answers are grounded in this paper and cite their sources.
Highlights the uncertainty regarding the long-term safety and risk of late thrombosis associated with drug-eluting stents.
Unanswered Questions — Drug-Eluting Stents and the Risk of Late Thrombosis By the end of 2004, drug-eluting stents were used in nearly 80% of percutaneous coronary interventions in the United States, and within 3 years, several million drug-eluting stents had been implanted worldwide. Dr. William Maisel writes that, unfortunately, much remains uncertain about the long-term safety of the devices.
No takes yet. Share an insight, caveat, or question.
William H. Maisel (2007) studied this question. Drug-eluting stents have an uncertain long-term safety profile regarding the risk of late thrombosis despite their widespread adoption in percutaneous coronary interventions.
Synapse has enriched 10 related papers. Consider them for comparative context: